Quest Diagnostics (DGX) Enterprise Value: 2009-2025
Historic Enterprise Value for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to $21.0 billion.
- Quest Diagnostics' Enterprise Value rose 26.28% to $21.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $19.9 billion, marking a year-over-year increase of 31.23%. This contributed to the annual value of $16.4 billion for FY2024, which is 23.41% up from last year.
- According to the latest figures from Q3 2025, Quest Diagnostics' Enterprise Value is $21.0 billion, which was up 5.78% from $19.8 billion recorded in Q2 2025.
- Quest Diagnostics' Enterprise Value's 5-year high stood at $21.0 billion during Q3 2025, with a 5-year trough of $13.3 billion in Q4 2023.
- In the last 3 years, Quest Diagnostics' Enterprise Value had a median value of $15.8 billion in 2024 and averaged $16.5 billion.
- As far as peak fluctuations go, Quest Diagnostics' Enterprise Value dropped by 15.75% in 2023, and later rose by 29.47% in 2025.
- Quarterly analysis of 5 years shows Quest Diagnostics' Enterprise Value stood at $14.9 billion in 2021, then grew by 5.76% to $15.7 billion in 2022, then fell by 15.75% to $13.3 billion in 2023, then grew by 23.41% to $16.4 billion in 2024, then climbed by 26.28% to $21.0 billion in 2025.
- Its last three reported values are $21.0 billion in Q3 2025, $19.8 billion for Q2 2025, and $19.3 billion during Q1 2025.